Informazioni sul prodotto
Nome:
Revatropate
Sinonimi:
- (3R-(3R*(S*(R*))))-1-Azabicyclo(2.2.2)oct-3-yl alpha-(hydroxymethyl)-alpha-(2-(methylsulfinyl)ethyl)benzenacetate
- (R)-3-Quinuclidinyl (S)-beta-hydroxy-alpha-(2-(R)-methylsulfinyl)ethyl)hydratropate
- Uk-112,166
- Unii-3W7L15V40W
- Benzenacetic acid, alpha-(hydroxymethyl)-alpha-(2-(methylsulfinyl)ethyl)-, 1-azabicyclo(2.2.2)oct-3-yl ester, (3R-(3R*(S*(R*))))-
- (3R)-1-azabicyclo[2.2.2]oct-3-yl (2S)-2-(hydroxymethyl)-4-[(R)-methylsulfinyl]-2-phenylbutanoate
Descrizione:
Revatropate is a chiral compound that belongs to the class of antimuscarinic drugs. It is used to treat motility disorders such as constipation, diarrhea, and irritable bowel syndrome. Revatropate has been shown to have high activity against syncytial virus infections and inflammatory bowel disease. This drug also inhibits the synthesis of phospholipase A 2 , which has been implicated in the pathogenesis of autoimmune diseases. The molecular mechanism for this effect is not known, but it may be due to the inhibition of water vapor loss from the bladder by reducing ileal motility.
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
365.49 g/mol
Formula:
C19H27NO4S
Purezza:
Min. 95%
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
